Cargando…

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

BACKGROUND: Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) play important roles in the turnover of extracellular matrix and in the pathogenesis of idiopathic pulmonary fibrosis (IPF). This study aimed to determine the utility of circulating MMPs and TIMPs in distinguishing pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, Newby, L. Kristin, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., Belperio, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071646/ https://www.ncbi.nlm.nih.gov/pubmed/32171287 http://dx.doi.org/10.1186/s12890-020-1103-4

Ejemplares similares

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
por: Todd, Jamie L., et al.
Publicado: (2019)

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
por: Todd, Jamie L., et al.
Publicado: (2022)

Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
por: Todd, Jamie L., et al.
Publicado: (2022)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
por: Salisbury, Margaret L., et al.
Publicado: (2020)

Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
por: Kim, Hyun J., et al.
Publicado: (2022)

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry
por: Swaminathan, Aparna C., et al.
Publicado: (2022)

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
por: Snyder, Laurie, et al.
Publicado: (2019)

Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
por: O'Brien, Emily C, et al.
Publicado: (2016)

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
por: Podolanczuk, Anna J., et al.
Publicado: (2022)

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
por: de Andrade, Joao A., et al.
Publicado: (2022)

Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
por: Ruan, Peifeng, et al.
Publicado: (2023)

Impact of pro-domain stability of matrix metalloproteinase-8 on the outcome of sepsis
por: McLaughlin, J, et al.
Publicado: (2011)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
por: Buss, Armin, et al.
Publicado: (2007)

Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
por: Chellaiah, Meenakshi A., et al.
Publicado: (2013)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
por: Dolmatov, Igor Yu., et al.
Publicado: (2021)

Diverse patterns of cyclooxygenase-independent metalloproteinase gene regulation in human monocytes
por: Reel, Buket, et al.
Publicado: (2011)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

The ADAM metalloproteinases
por: Edwards, Dylan R., et al.
Publicado: (2008)

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry
por: King, Christopher S., et al.
Publicado: (2023)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD
por: Heijink, Irene H, et al.
Publicado: (2011)

Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors
por: Gömöri, Kamilla, et al.
Publicado: (2020)

The regulation of trophoblast invasion and decidual reaction by matrix metalloproteinase‐2, metalloproteinase‐7, and metalloproteinase‐9 expressions in the rat endometrium
por: Hamutoğlu, Rasim, et al.
Publicado: (2020)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles
por: Alameddine, Hala S., et al.
Publicado: (2016)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
por: Behr, Jürgen, et al.
Publicado: (2015)

Study of matrix metalloproteinases and their inhibitors in breast cancer
por: Vizoso, F J, et al.
Publicado: (2007)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

Tissue inhibitors of metalloproteinases
por: Murphy, Gillian
Publicado: (2011)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Metalloproteinases in Ovarian Cancer
por: Carey, Preston, et al.
Publicado: (2021)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases Are Essential for the Inflammatory Response in Cancer Cells
por: Sun, Jun
Publicado: (2010)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in murine β-coronavirus-induced neuroinflammation
por: Sengupta, Sourodip, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31svbet98fc055cs5ocfspabqk